House Oversight Chair Demands PBM Executives Correct False Testimonies

Chairman James Comer's Demand:
House Oversight and Accountability Committee Chairman James Comer has called on executives from CVS Caremark, Express Scripts, and OptumRx to correct their testimonies made during a July hearing, citing contradictions with committee and FTC findings.

False Statements:
The executives claimed they do not steer patients to PBM-owned pharmacies and made other statements that contradict bipartisan findings and the experiences of pharmacists.

Potential Consequences:
Comer highlighted that making false statements to Congress can result in fines and imprisonment of up to five years.

Industry Scrutiny:
The FTC has accused PBMs of favoritism towards their own pharmacies, affecting medication access and affordability, and is preparing lawsuits against UnitedHealth, Cigna, and CVS.

Reform Calls:
The National Community Pharmacists Association (NCPA) emphasizes the need for PBM reforms this year, stating that PBMs will only change their practices if forced to do so.